Federal award
KBR WYLE SERVICES, LLC
0009
Contract
Obligated and Ceiling
- Obligated (net)
- $30,625,727.34
- Ceiling (potential value, not spending)
- $31,065,928.01
- Current value
- $30,741,754.87
- Gross positive obligations
- $31,083,009.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- KBR WYLE SERVICES, LLC · L693MQDFLKD1
- Owner company
- KBRBasis reviewed link: a dated, evidenced ownership link.
- Reported parent
- KBR WYLE SERVICES, LLC · TGPKTMN8YL31
- Awarding agency
- Department of Defense · sub-agency 5700 · office FA8075
- Funding agency
- Department of Defense · sub-agency 97AD
- Product or service (PSC)
- AZ12 · R&D- OTHER RESEARCH AND DEVELOPMENT (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT)
- Industry (NAICS)
- 541712 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY)
- PIID
- 0009
- Parent vehicle (IDV PIID)
- FA807514D0025
- Award type code
- C
- Actions
- 29 · Jun 17, 2016 to Aug 6, 2025
- Why it is listed
- gross positive obligations of $100k or more (contracts); reviewed company, $10k or more
Action History29
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Aug 6, 2025 | FY2025 | 27 | C | −$330.61 | |
| May 31, 2022 | FY2022 | A00001 | M | −$324,173.14 | |
| Feb 12, 2022 | FY2022 | 26 | M | $0.00 | |
| Sep 13, 2021 | FY2021 | 25 | A | −$81,710.59 | |
| Sep 9, 2021 | FY2021 | 24 | C | −$33,986.33 | |
| Sep 26, 2019 | FY2019 | 23 | B | $227,723.00 | |
| May 28, 2019 | FY2019 | 22 | C | −$17,080.99 | |
| Nov 8, 2018 | FY2019 | 21 | C | $0.00 | |
| Jun 14, 2018 | FY2018 | 20 | C | $1,382,446.00 | |
| May 18, 2018 | FY2018 | 19 | C | $1,396,044.00 | |
| Jan 18, 2018 | FY2018 | 18 | C | $352,205.00 | |
| Sep 7, 2017 | FY2017 | 17 | B | $675,000.00 | |
| Aug 1, 2017 | FY2017 | 16 | C | $5,283,681.00 | |
| Jul 18, 2017 | FY2017 | 15 | C | $2,012,374.00 | |
| Jun 27, 2017 | FY2017 | 14 | C | $1,928,471.00 | |
| Jun 13, 2017 | FY2017 | 13 | M | $0.00 | |
| Jun 8, 2017 | FY2017 | 12 | C | $1,249,873.00 | |
| Apr 28, 2017 | FY2017 | 11 | M | $29,544.00 | |
| Mar 16, 2017 | FY2017 | 10 | B | $0.00 | |
| Feb 21, 2017 | FY2017 | 9 | C | $3,024,227.00 | |
| Jan 13, 2017 | FY2017 | 8 | C | $182,000.00 | |
| Jan 9, 2017 | FY2017 | 7 | B | $0.00 | |
| Nov 9, 2016 | FY2017 | 6 | C | $58,938.00 | |
| Sep 23, 2016 | FY2016 | 5 | C | $292,000.00 | |
| Sep 13, 2016 | FY2016 | 4 | C | $2,991,500.00 | |
| Aug 4, 2016 | FY2016 | 3 | C | $2,369,920.00 | |
| Jul 13, 2016 | FY2016 | 2 | C | $2,159,961.00 | |
| Jun 24, 2016 | FY2016 | 1 | C | $3,446,347.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jun 17, 2016 | FY2016 | 0 | — | $2,020,755.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.